文献速递糖尿病

转录因子STAT6在促进β细胞存活中起关键作用,且在1型糖尿病患者胰岛中耗竭

The transcription factor STAT6 plays a critical role in promoting beta cell viability and is depleted in islets of individuals with type 1 diabetes.
PubMed 文献 · Diabetologia · 2018-10-18

该研究探讨IL-4/IL-13通过STAT6对β细胞的细胞保护作用。在克隆β细胞、分离人胰岛及胰腺切片中发现,IL-4/IL-13早期激活STAT6,上调抗凋亡蛋白MCL-1、BCLXL及SIRPα,敲低STAT6则丧失保护效应;1型糖尿病患者β细胞中STAT6明显耗竭,提示其选择性丢失可能促进β细胞死亡。

要点

  • IL-4/IL-13通过早期激活STAT6上调抗凋亡蛋白MCL-1和BCLXL,发挥β细胞保护作用。
  • 敲低STAT6可消除上述抗凋亡蛋白的诱导及细胞保护效应,敲低SIRPα则降低β细胞活力。
  • 1型糖尿病患者胰腺β细胞中STAT6明显耗竭,提示细胞保护反应丧失。

核心结论

  • STAT6的选择性丢失可能促进1型糖尿病进展过程中的β细胞死亡。

研究设计与样本

  • 研究采用克隆β细胞、分离的人胰岛以及对照个体和1型糖尿病患者的胰腺切片。
  • 基因表达用靶向基因芯片和定量RT-PCR检测,蛋白表达用Western blot和免疫细胞化学检测,并用干扰RNA选择性敲低目标蛋白。

主要发现

  • IL-4和IL-13的细胞保护作用由β细胞中信号转导和转录激活因子6(STAT6)的早期激活介导,上调抗凋亡蛋白包括髓细胞白血病-1(MCL-1)和B细胞淋巴瘤-extra large(BCLXL)。
  • 研究还报告了信号调节蛋白-α(SIRPα)的诱导,且敲低SIRPα与β细胞活力降低相关。
  • 在β细胞中siRNA介导敲低STAT6后,这些抗凋亡蛋白及其伴随的细胞保护效应丧失。
  • 人胰腺切片分析显示,1型糖尿病个体β细胞中STAT6明显耗竭,提示细胞保护反应丧失。

临床怎么用

  • STAT6及其下游抗凋亡通路可能作为评估1型糖尿病β细胞保护状态的标志,但尚需进一步验证。

局限性

  • 研究未报告样本量、具体统计数值及置信区间,且主要基于体外细胞和离体组织分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: In type 1 diabetes, selective beta cell loss occurs within the inflamed milieu of insulitic islets. This milieu is generated via the enhanced secretion of proinflammatory cytokines and by the loss of anti-inflammatory molecules such as IL-4 and IL-13. While the actions of proinflammatory cytokines have been well-studied in beta cells, the effects of their anti-inflammatory counterparts have received relatively little attention and we have addressed this. METHODS: Clonal beta cells, isolated human islets and pancreas sections from control individuals and those with type 1 diabetes were employed. Gene expression was measured using targeted gene arrays and by quantitative RT-PCR. Protein expression was monitored in cell extracts by western blotting and in tissue sections by immunocytochemistry. Target proteins were knocked down selectively with interference RNA. RESULTS: Cytoprotection achieved with IL-4 and IL-13 is mediated by the early activation of signal transducer and activator of transcription 6 (STAT6) in beta cells, leading to the upregulation of anti-apoptotic proteins, including myeloid leukaemia-1 (MCL-1) and B cell lymphoma-extra large (BCLXL). We also report the induction of signal regulatory protein-α (SIRPα), and find that knockdown of SIRPα is associated with reduced beta cell viability. These anti-apoptotic proteins and their attendant cytoprotective effects are lost following siRNA-mediated knockdown of STAT6 in beta cells. Importantly, analysis of human pancreas sections revealed that STAT6 is markedly depleted in the beta cells of individuals with type 1 diabetes, implying the loss of cytoprotective responses. CONCLUSIONS/INTERPRETATION: Selective loss of STAT6 may contribute to beta cell demise during the progression of type 1 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Leslie KA, Russell MA, Taniguchi K, et al. The transcription factor STAT6 plays a critical role in promoting beta cell viability and is depleted in islets of individuals with type 1 diabetes. Diabetologia. 2018. PMID: 30338340. doi:10.1007/s00125-018-4750-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。